Animal Genetics Market - Global Demand, Sales,COVID-19 Impact Analysis, Consumption and Forecasts to 2023

 According to the Market Research Future (MRFR) analysis, the global animal genetics market size is estimated to register a CAGR of 8.4% from 2018 to 2023 (forecast period). The report offers an in-depth overview of the industry, including production, suppliers, quality, consumption, growth rate, profit margins, services, imports and exports, and technology advancements.

Animal genetics is a field of genetics that is dedicated to the study of genetic variability and inheritance, especially for domestic and wild animals. For commercial purposes, animal genetics is used for DNA typing, genetic disease testing, and genetic trait testing. This methodology uses a hybrid population, ontogenetic, and cytological studies to determine genetic hybridizations. For example, genetically modified cows may be able to produce more milk and may be less vulnerable to common cattle diseases, such as clostridial disease, bovine respiratory disease complex, etc., thereby increasing the overall income of cattle farmers.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7004 

Market Dynamics  

The significant factor responsible for influencing this market is the increase in the consumption of animal-derived protein, the growth of the global population, and rapid urbanization. The increasing focus on the identification of superior breeds has contributed to the growth of the market for toxicology testing. 

However, factors such as the substantial cost of animal testing, the stringent regulatory framework for genetic engineering, and the lack of qualified professionals are expected to inhibit the market growth during the forecast period.

Segmentation

The global market for animal genetics market is segmented based on animal genetic products, services, and end-users. 

Based on animal genetic products, the global market for animal genetics market is segmented into genetic materials and live animals. The live animals are further divided into poultry, bovine, porcine, canine, and others. The genetic materials are sub-segmented into semen and embryo. 

Based on services, the global market for animal genetics is segmented into genetic disease tests, DNA typing, gene trait tests, and others. 

Based on end-user, the global market for animal genetics is segmented into veterinary hospitals & clinics, diagnostic centers, research centers and institutes, and others.

Regional Analysis

Regionally, the global animal genetics market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominated the global market for animal genetics in 2017. This was due to the growth in the North American region, primarily due to factors such as growing demand for animal products such as pork and mutton. Moreover, rapid urbanization is likely to spur market demand for live animals in the coming years. Growing adoption of artificial insemination, particularly in cattle, sheep, pigs, and goats, is fueling the market growth.

Europe was the second-largest region for the global animal genetics market. Due to rising awareness of animal health, the increase in the number of numerous animal genetic diseases, and the increased prevalence of the zoonotic disease is projected to provide this market with profitable growth opportunities.

The Asia Pacific was expected to be the fastest-growing area on the global market for animal genetics in 2017. Factors due to the increasing population of livestock and the development of DNA typing and genetic testing methods further increase the demand for genetic trait tests and various diagnostic tests.

Key players

Some of the major participants in the global animal genetics market are Neogen Corporation (US), Genus (UK), URUS (US), Groupe Grimaud (France), Animal Genetics (US), CRV Holding B.V. (The Netherland), Topigs Norsvin (Netherlands), Zoetis (US), EW Group (Germany), Envigo (US) Hendrix Genetics BV (The Netherland), Alta Genetics (US), vetGen (US), and others.

Browse Complete Report With Consider Covid19 Impact @  https://www.marketresearchfuture.com/reports/animal-genetics-market-7004 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Augmented Reality in Healthcare Market Status, Price, COVID-19 Pandemic Impact, Business Opportunities, Key Findings and Industry Outlook 2023

 The global augmented reality in healthcare market is projected to expand at a CAGR of 23% during the forecast period from 2017 to 2023 to reach a valuation of USD 1.32 billion by 2023. This growth is attributable to the surge in population and increasing demand for effective surgical treatments. Additionally, the rise in the penetration of connected devices along with a rise in investment for the advancement of products is driving growth of the global augmented reality in healthcare market. The demand for handheld and head-mounted display for connecting with several other devices, including gestures, voice commands, and motion tracking, is estimated to provide traction for growth of the market.

Furthermore, the surge in penetration of mobile-based applications, artificial intelligence, and cloud-based AR applications, along with the introduction of 5G networking for hospital use, is likely to offer the most lucrative opportunities for growth in the coming years. The mobile-based applications is increasing the accessibility and popularity of augmented reality. Additionally, faster services provided by these applications are bridging the gap between patients and healthcare providers. Thus, the players are looking to offer newer products through research and development, partnerships, and collaboration. For instance, VITAS publicized collaboration with AT&T for exploring the potential launch of 5G networking, especially in hospital operations. With 5G, augmented reality and other advanced technologies work faster for reducing the pain of patients.

High prevalence of chronic and life-threatening diseases and other diseases such as HIV, diabetic, and dementia patients is further augmenting demand for advanced technologies is fueling growth of the global augmented reality in healthcare market. Additionally, technological innovations enhance the communications helps to improve tracking of patient’s health and communication with healthcare providers. These factors are driving growth of the global augmented reality in healthcare market.

Competitive Analysis:

Some of the key players in the global augmented reality in healthcare market include DAQRI, Microsoft Corporation, Mindmaze, Atheer, Wikitude GmbH, Medical Realities, Augmedix, 3D Systems, Oculus VR, CAE Healthcare, Google LLC., Blippar, Philips Healthcare, Siemens Healthineers, HTC, VirtaMed, Osterhout Design Group, and Magic Leap, Inc. Newer product launches are driving growth of the global augmented reality in healthcare market.

Segmentation:

The augmented reality in the healthcare market is segmented based on component, application, device type, and region.

In terms of components, the augmented reality in healthcare market is categorized into software, hardware, and others. The hardware segment is further bifurcated into sensors, position trackers, displays and projectors, cameras, and others.

Based on the application, the augmented reality in healthcare market is segmented into medical training and education, fitness management, and others.

Based on the device type, the augmented reality in healthcare market is segmented into the handheld device, head-mounted display, and others.

Regional Analysis:

Based on the region, the augmented reality in healthcare market is segmented into Europe, North America, Asia Pacific, and the Rest of the World. Of these, North America is the dominant region and is estimated to be the same in the coming years owing to a huge demand for AR to be used in a range of healthcare devices for enhanced screening and treatments. Europe stood for the second position in terms of revenue due to an increase in investment for the adoption of advanced techniques in the healthcare sector.

However, a surge in investment, as well as the presence of a large patient’s pool in the Asia Pacific, is estimated to expand by exhibiting at the largest CAGR in the coming future. By tracing the presence of robust opportunities, the key players are increasingly launching newer products with several features, which is also benefiting the augmented reality in healthcare market growth in the region.

Industry News: 

In 2019, XRHealth, one of the leaders in the extended reality and therapeutic applications, announced its partnership with Allscripts. Through this partnership, enables medical professionals to monitor patient health through AR therapies and boosts its accessibility, penetration, and applications.

Read More @ https://www.marketresearchfuture.com/reports/augmented-reality-in-healthcare-market-5236 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

Breast Biopsy Market Challenges, COVID-19 Impact Analysis, Competitive Landscape and Gross Margin Analysis till 2023

 A biopsy is a small operation that is used to perform the removal of tissues from an area of concern from the body. Breast biopsy is a medical procedure that involves the testing of small samples of breast tissues for the detection of breast cancer. This form of biopsy is conducted with the help of minimally invasive biopsy systems due to minimal pain and disfigurement. There are various types of biopsy procedures that are used depending upon the different techniques like vacuum-assisted biopsy (VAB), core needle biopsy (CNB), and fine needle aspiration biopsy (FNAB). These are recommended by the doctor based on the size, location, and other characteristics of the breast abnormality. The global breast biopsy market is expected to expand in significant fashion during the forecast period of 2018 to 2023.

The increasing prevalence of breast cancer, especially for women above 35 years of age during menopause, who are more susceptible to breast cancer, and rising awareness concerning breast cancer screening programs are the major drivers of the market. However, there are various constraints limiting the market growth as well. This includes the infection risks associated with breast biopsy procedures, unspecified regulatory issues, and ambiguous reimbursement policies. In addition to these, the market growth is also restricted due to the high cost of surgical procedures and the risks associated with them. At the same time, the emergence of technologically-advanced and the usage of breast biopsy devices that are minimally invasive are expected to tap into the potential opportunities that the market holds. 

Market Segmentation

The global breast biopsy market segmentation is done as per technique type, product, guidance technology, and end-user. 

By product, the market includes biopsy tables, guidance systems, biopsy needles, biopsy wires, and others.

By technique type, the market includes core needle biopsy, fine needle aspiration biopsy, wire localization, MRI-guided core needle biopsy, biopsy markers, surgical biopsy, and sentinel node biopsy. The core needle biopsy segment is further segmented into vacuum-assisted biopsy, stereotactic core needle biopsy, ultrasound-guided core biopsy, and freehand core-needle biopsy. The surgical biopsy segment is divided into excisional biopsy and incisional biopsy.

By guidance technology, the market includes CT-guided biopsy, ultrasound-guided, mammography-guided magnetic resonance, and various other image-guided breast biopsy (PET and thermography).

By end-user, the market comprises of ambulatory surgical centers, hospitals, diagnostic centers, and others. 

Read Complete Report @ https://www.marketresearchfuture.com/reports/breast-biopsy-market-6288 

Regional Analysis

The geographical breast biopsy market segmentation covers four major regions, namely North America, Asia-Pacific, Europe, and the Middle East & Africa. 

North America is anticipated to hold the largest market share over the forecast period as per the market report published by MRFR. This is primarily due to the early adoption of advanced medical technologies and a continued emphasis on the development from companies operating in cancer diagnostics. The Europe market holds the second-largest share of the breast biopsy market due to the striking prevalence of breast cancer in the UK and Belgium. Both North America and Europe comprise more than 50% of the of the global breast biopsy market share. 

The regional market of Asia-Pacific is also slated to experience a period of growth in the forthcoming years. This is because of the demand for advanced technology, better rate of adoption of such technologies, access to optimal treatment facilities, increasing favorable initiatives undertaken by the government, and rising healthcare expenditure. 

Lastly, the Middle East & Africa region is expected to garner the least market growth due to the presence of an underdeveloped healthcare industry, poor medical facilities, and lack of technical proficiency and knowledge concerning the operation. 

Competitive Landscape

The global breast biopsy market includes a number of leading market players, including Cook Medical Incorporated, Dickinson and Company, NuVue Therapeutics, Argon Medical Devices, Inc., Johnson & Johnson, Encapsule Medical Devices LLC., Leica Biosystems, C.R. Bard Inc., Argon Medical Devices, Hologic Inc., Devicor Medical Products Inc., Becton, Hologic Inc., Karl Storz GmbH & Co. Kg, GE Healthcare., Intact Medical Corporation, Conceptus INC, and Galini SRL.

October 30th, 2019, a team from ETH Zurich with support from the Swiss National Science Foundation developed a new ultrasound method to help differentiate benign breast tumors from the malignant ones. The clinical trials have proven to show great promise in the detection of breast cancer and can be revolutionary in the medical segment for detecting breast cancer. 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

Immunofluorescence Assay Market by Top Manufacturers, COVID-19 Pandemic Impact, Applications, Supply, Consumption, Demand and Forecast to 2023

Global Immunofluorescence Assay Market Research Report, by Technique (Primary, Secondary), by Product Type (Antibodies, Kits), by Application (Clinical research), End-User (Clinical Diagnostics, Hospitals & Research Institutes) - Global Forecast Till 2023

The global immunofluorescence assay market is growing pervasively. The market growth attributes to the increase in biological studies in R&D for the detection of biomolecules like glycans, proteins, and small biological and non-biological molecules of various diseases. Also, immunofluorescence assays are primarily used for rapid and sensitive diagnostics of various chronic diseases such as cancer, autoimmune diseases, infectious diseases like HIV, neurological disorders such as Alzheimer's and Parkinson's diseases.

Request a Sample Copy of the Research Report@ https://www.marketresearchfuture.com/sample_request/6177 

With the intervention of the COVID-19, the immunofluorescence assay industry is witnessing a massive demand across the globe. This is due to the rising usages of immunofluorescence assays in the development of antibodies that can detect sars-Cov-2 in patient samples. According to Market Research Future (MRFR), the global immunofluorescence assay market is projected to register 5.8% CAGR during the analysis period (2017–2023). 

Advancements in medical technology, alongside the increasing R&D funding by industry leaders and governments, boost the market growth. Additionally, rising numbers of preclinical research, alongside the rising studies on antibody therapies, advanced drug discoveries, and oncology diseases, accelerate the market growth. Growing collaborations between research institutes and biotechnology companies are expected to drive the growth of the immunofluorescence assay market.

Conversely, the high cost of immunofluorescence assay products such as diagnostic kits is expected to restrict the market growth during the forecast period. Also, factors such as risks of cross contaminations and shortage of skilled labor & weak detection signals are estimated to impede the growth of this market.  Nevertheless, growing advancements in biotechnology & medical science would support the growth of the market, bringing about cost-effective immunofluorescence assay.  

Intended Audience

• Pharmaceutical companies
• Biotechnological institutes
• Government and private laboratories
• Research and Development (R&D) companies
• Medical research laboratories
• Market research and consulting service providers

Global Immunofluorescence Assay Market – Segmentation

The report is segmented into five dynamics;  

By Technique : Primary (Direct) Immunofluorescence Assays and Secondary (Indirect) Immunofluorescence Assays (Salt split technique, Antigenic mapping method, Double Staining method), Micro Immunofluorescence. 

By Product Type : Antibodies, Kits & Reagents, Instruments, Microscopes, Imaging Analysis Systems, Labeling dyes, Species Product Type, and others. 

By Application : Clinical Research, Clinical Diagnostics, Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Neurological Diseases, Research & Development, and others. 

By End-User : Biotechnology Companies, Hospitals & Research Institutes, Contract Research Organizations, Diagnostic centers, and others.

By Regions :  Americas, Europe, Asia Pacific, and Rest-of-the-World.

Global Immunofluorescence Assay Market – Regional Analysis

North America dominates the global immunofluorescence assay market. The largest market share attributes to the high prevalence of chronic diseases and rising R&D investments within this region. Also, the rising adoption of advanced systems for early diagnosis of diseases drives the regional market growth. Moreover, the advancement in the development techniques and increasing use of nanotechnology in the development of immunofluorescence assay fostered the growth of the regional market. 

The US, among other North American countries, holds the largest share in the regional market. Besides, the presence of vast numbers of biotechnology & pharmaceutical companies impacts the regional market growth positively. The North American immunofluorescence assay market is estimated to retain its leading position throughout the assessment period.

Europe stands second in the immunofluorescence assay market. The market is driven by the increasing prevalence of myriads of chronic diseases such as cancer and the rapidly growing biotechnology sector in Europe. Moreover, substantial R&D investments by the public and private sectors, alongside the increasing R & D in biotechnology, foster the market growth in the region. The European immunofluorescence assay market is projected to create a substantial revenue pocket over the review period. 

The immunofluorescence assay market in the Asia Pacific region is growing rapidly. Factors such as the growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure, and increasing R&D activities in the biotechnology sector influence the market in this region. Also, the presence of major market players in China, India, and Japan drive market growth. Rising government initiatives increase the size of the immunofluorescence assay market in the region. 

The region witnesses rising developments of immunofluorescence assay products, while several products are under the pipeline, which is carried out under license agreements. The APAC immunofluorescence assay market is expected to grow at an impressive CAGR during the predicted period.

 

Global Immunofluorescence Assay Market – Competitive Analysis 

Highly competitive, the global immunofluorescence assay market appears fragmented due to the presence of several well-established players. To gain a larger competitive advantage, players incorporate strategies such as mergers & acquisitions, collaborations, expansion, and product/technology launch. Top players make huge investments for R&D and clinical trials to develop these assays. Pharmaceutical companies are the largest investors in the immunofluorescence assay market. 

Major Players: 

Players leading the global immunofluorescence assay market include Abcam plc., Thermo Fisher Scientific, BioLegend, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., BioTek Instruments, Inc., Bio-Rad Laboratories, Inc., Zyagen Cell Signaling Technology, Inc., PerkinElmer Inc., Becton Dickinson and Company, Merck, Agilent Technologies, TCS Biosciences Ltd, and Maxvision Biosciences Inc., among others. 

Industry/Innovation/ Related News:

May 29, 2020 --- Rockland Immunochemicals Inc. (the US), a leading global biotechnology company, announced the development of a critical antibody reagent essential to antibody tests used to determine SARS-CoV-2 exposure for patients suspected to have contracted COVID-19. The antibody specifically reacts with the SARS-CoV-2 Nucleocapsid protein present in patient samples and has shown in various independent testing laboratories in regions highly specific and sensitive for SARS-CoV-2.

Rockland manufactures tools for basic, applied, and clinical research in functional genomics, gene therapy, and drug discovery markets. It offers each academic, biopharma, and professional diagnostic thousands of antibodies to provide the right antibody that is the perfect fit for every occasion. The newly developed antibody has proven effective in lateral flow assays (immunochromatography), ELISA, Western blotting, Immunofluorescence microscopy, fluorescence-activated cell sorting, and immunohistochemistry.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Immunofluorescence Assays Market, By Technique

6.1 Introduction

6.2 Primary (Direct) Immunofluorescence Assays

6.2 Secondary (Indirect) Immunofluorescence Assays

 

Continued….

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/immunofluorescence-assay-market-6177 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Diabetic Retinopathy Market 2021 Current Trends, COVID-19 Impact Analysis, Future Growth Study, Strategic Assessment and Demand by Forecast to 2023

 Global Diabetic Retinopathy Market Research Report: Information by Type (Non-proliferative and Proliferative), Treatment (Anti-VEGF Drugs, Laser Photocoagulation, Vitreoretinal Surgery, Steroid Injection), by End User (Hospitals, Ambulatory Surgical Centers, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025

Diabetic Retinopathy Market Scenario

The global diabetic retinopathy market is predicted to expand at 11.9 % CAGR during the forecast period (2018-2025), asserts Market Research Future (MRFR). This can be attributed to the growing patient population over the years. Diabetic retinopathy is usually referred to eye diseases in diabetic patients. High blood sugar level causes the blood vessels in the retina to damage which results in leakage and swelling of the blood vessels, thus stopping blood to pass through. Some of the common symptoms of diabetic retinopathy involve blurred vision, vision loss, dark strings or spots floating in the vision, impaired color vision, and empty or dark areas in your vision.

Get FREE Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.marketresearchfuture.com/sample_request/5792 

Future Drivers and Constraints Impacting the Diabetic Retinopathy Market

Complications such as retinal detachment, blindness, vitreous hemorrhage, and glaucoma associated with diabetic retinopathy can result to loss of vision. Availability of treatment in the market, growing awareness about diabetic retinopathy, and growing prevalence of diabetes are propelling the market over the review period. With the growing demand for diagnostic tests for early detection also drives the market for diabetic retinopathy. Moreover, increasing disposable income along with the fear of vision loss has resulted in the patients to avail the required treatment. Availability of advanced technology along with minimal pain reducing laser treatment is expected that the patients adopt surgical treatment. This is further estimated to impact the market positively over the review period.

On the flip side, lack of awareness about diagnosis and treatment along with inaccuracy in the diagnostic test among the geriatric population are factors inhibiting the market growth over the assessment period.

Global Diabetic Retinopathy Market Segmentation

The global diabetic retinopathy market has been segmented based on diagnosis, type, indication, treatment, end-user, and region.

By mode of type, the global market for diabetic retinopathy has been segmented into proliferative advanced diabetic retinopathy and non-proliferative diabetic retinopathy. Among these, the non-proliferative diabetic retinopathy dominates the market due to the presence of a large number of patient population. Non-proliferative diabetic retinopathy is also known as background retinopathy which is the most common diabetic eye condition is causing blindness among the adults.

By mode of diagnosis, the global market for diabetic retinopathy has been segmented into anti-VEGF therapy, laser treatment, and vitrectomy. The laser treatment has been sub-segmented into scattering laser treatment and focal laser treatment. Among these, the segment for anti-VEGF therapy has been estimated to dominate the market due to high applicability of drugs in early diagnosis, fast recovery, and better treatment.

By mode of end-user, the global market for diabetic retinopathy has been segmented into diagnostic centers, hospitals and clinics, research institutes, and others.

Regional Analysis

Geographically, the market for diabetic retinopathy spans across America, Europe, Asia Pacific, and the Middle East and Africa.

America holds the largest market share owing to the growing focus on early diagnosis and diagnostic imaging. The U.S. being the largest market in the North American region, is driven by growing number of diagnostic tests in clinics and hospitals and high count of diabetic patients. Emphasis on preventive care and presence of major market players are also likely to stimulate the market growth during the assessment period.

In Europe, the market for diabetic retinopathy is mainly driven by the availability of treatment options and growing patient population in this region. With the rising importance of early diagnosis and treatment and growing emphasis on diabetes management are also estimated to trigger the market growth in this region. Germany is the largest contributor in this region due to high investment in R&D on lifestyle diseases such as cardiovascular disease, diabetes, obesity, and others.

In Asia Pacific region, the growth of the market is stimulated due to prevalence of chronic diseases like diabetes and obesity. Also, the presence of a high count of the geriatric population has also contributed to the market growth over the assessment period.

Moreover, the Middle East and African region showcase a steady growth owing to the growing number of diagnostic services and rising demand for diabetes management. The United Arab Emirates and Saudi Arabia are the largest contributors responsible for the market growth in this region.

Industry News

A group of graduate students from California Institute of Technology has designed glowing contact lenses to treat diabetic retinopathy. The lenses can be worn while sleeping, emitting enough of glow for the retina to detect. These lenses help to preserve the cells and the patient’s eyesight.

Competitive Analysis

Some of the prominent players operating the global market for diabetic retinopathy are BCN Peptides (Spain), Ampio Pharmaceuticals (U.S.), Novartis AG (Germany), Kowa Group (Japan), Bayer (Germany), Alimera Sciences (U.S.), Glycadia Pharmaceuticals (U.S.), Genentech (U.S.), Sirnaomics (U.S.), Actavis Plc (U.K.), Regeneron Pharmaceuticals Inc. (U.S.), ThromboGenics (U.S.), and others.

You Can Access Full report : https://www.marketresearchfuture.com/reports/diabetic-retinopathy-market-5792

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Atrial Fibrillation Market Expected To Boost The Industry Across The Globe

 Market Highlights

The global atrial fibrillation market is estimated to account for USD 11123.8 million and registering a CAGR of ~ 11.2 %. Atrial fibrillation is a disorder of the pace or the rhythm of the heart. It is caused by unsystematic electrical activity in the atria of the heart, which causes rapid stimulus of the ventricles, leading to an irregular heartbeat. Numerous factors such as advancements in minimally invasive surgeries to treat atrial fibrillation, appropriate and timely intervention of the healthcare delivery systems, and increased incidence rates of the risk factors are expected to drive the growth of the market during the forecast period. According to the Centers for Disease Control and Prevention, Atrial fibrillation (AFib) costs the United States about USD 6 billion annually. Medical costs for people who have AFib are about USD 8,705 higher per year than for people who do not have AFib. Therefore, the ability of the specialist to suspect and diagnose the condition is very important. The lack of technical knowledge and misdiagnosis and mismanagement of the condition may hamper the market growth.

The global atrial fibrillation market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in January 2017, Abbott completed the acquisition of St. Jude Medical, Inc. St. Jude Medical's strong positions in fast-growing areas such as atrial fibrillation, heart failure, structural heart and chronic pain balance Abbott's leading positions in coronary interventions and mitral valve disease and will further create a strong and diverse product portfolio.

Access Report @ https://www.marketresearchfuture.com/reports/atrial-fibrillation-systems-market-6520 

Regional Analysis

The market in the Americas is expected to dominate the global atrial fibrillation market during the forecast period due to the escalation in the adoption of advanced technologies and procedures for the treatment of atrial fibrillation, and well-developed healthcare infrastructure. According to the Centers for Disease Control and Prevention in 2017, an estimated 2.7–6.1 million people in the United States have atrial fibrillation (AFib). The European market is expected to be the second-largest due to government funding and support of the healthcare sector. Also, many companies are setting up their research and development centers in this region, which will boost the market growth in this region. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to growing disposable income, and huge population susceptible to cardiovascular diseases. The market in the Middle East & Africa is likely to account for the smallest share of the global atrial fibrillation market.

Segmentation

The global atrial fibrillation market has been segmented into type, treatment, and end-user.

The market, on the basis of type, has been segmented into paroxysmal atrial fibrillation, persistent atrial fibrillation, and permanent atrial fibrillation.

The permanent type of atrial fibrillation is anticipated to hold the largest share as it is the most common type of AFib with a high occurrence rate. The persistent atrial fibrillation segment is estimated to be the fastest growing owing to increased recurrence rates in patients.

The market, on the basis of treatment, has been segmented into medications, non-surgical procedures, and surgical procedures.

The market, based on medications, has been segmented blood thinners, rate controllers, and rhythm controllers.

The market, based on non-surgical procedures, has been segmented into electrical cardioversion and catheter ablation.

The market, based on surgical procedures, has been segmented into pacemaker implantation and open-heart maze procedure.

Key Players

Some of the key players in the global atrial fibrillation market are Medtronic Plc, Johnson & Johnson Services, Inc., Abbott, Boston Scientific Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, Koninklijke Philips N.V., AtriCure, Inc., CardioFocus, Osypka AG, Siemens AG, Biosense Webster, Inc., Sichuan Jinjiang Electronic Science and Technology Co., Ltd., CathRx Ltd., and Vanguard AG.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/